Ora
Mark Abelson is a distinguished ophthalmologist and clinical researcher, recognized as the founder of Ora, Inc., a leading ophthalmic clinical research firm established in 1979, which has facilitated 38 FDA approvals over three decades. Abelson holds an Honorary Doctor of Science from Bates College and served as Surgeon Emeritus at the Massachusetts Eye and Ear Infirmary. Additionally, a part-time professor at Harvard Medical School from 2010 to 2015, Abelson has held several academic and clinical positions, contributing to the Schepens Eye Research Institute as a Trustee and Clinical Senior Scientist, and serving as a Senior Surgeon at both Lawrence General Hospital and Holy Family Hospital from 1977 to 2015. Educational credentials include a Doctor of Medicine from McGill University, where Abelson also completed an ophthalmology residency, and a Bachelor of Applied Science in Medicine.
This person is not in any teams
This person is not in any offices
Ora
1 followers
Ora is the world's leading full-service ophthalmic drug and device development firm with offices in the United States, United Kingdom, Australia, and Asia. They support a wide array of organizations, from start-ups to global pharmaceutical and device companies, to efficiently bring their new products from concept to market. They bring together the world's most extensive and experienced team of ophthalmic experts, R&D professionals, and management executives to maximize the value of new product initiatives.